Yoshikazu Honda‐Okubo

Also affiliated with Vaxine (Australia), West Australian Sleep Disorders Research Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age”.

A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age

Vaccine(2025)10.1016/j.vaccine.2025.126991

N/A

0.226DataRank · unranked

3 citations

Emmanuel B. Walter, Michael J. Smith, James Campbell, Hana M. El Sahly, Jennifer A. Whitaker +20 more

Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults

Vaccine(2025)10.1016/j.vaccine.2025.126744

N/A

0.130DataRank · unranked

1 citations

Dimitar Sajkov, Bruce A. Wauchope, Joseph V. Turner, Brendan J. Vote, Anna Antipov +4 more

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines

Pathogens(2021)10.3390/pathogens10050500

N/A

0DataRank · unranked

18 citations

Jeremy Baldwin, Nikolai Petrovsky, Yoshikazu Honda‐Okubo

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.03.451026

N/A

0DataRank · unranked

8 citations

Yoshikazu Honda‐Okubo, Ying Huang, Hyesun Jang, Michael A. Carlock, Jeremy Baldwin +12 more

An Advax-adjuvanted Inactivated Cell-culture Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-flavivirus Antibodies and T-cell Immunity and Provides Single Dose Protection

Preprints.org(2021)10.20944/preprints202110.0034.v1

N/A

0DataRank · unranked

3 citations

Yoshikazu Honda‐Okubo, Jeremy Baldwin, Nikolai Petrovsky, Tomoyoshi Komiya

Accelerated vaccine induction of IgM neutralising antibody enables vaccine protection against same day lethal influenza virus challenge

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.17.431751

N/A

0DataRank · unranked

0 citations

Lei Li, Jeremy Baldwin, Nikolai Petrovsky, Yoshikazu Honda‐Okubo

Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters

Vaccine(2022)10.1016/j.vaccine.2022.04.041

N/A

0DataRank · unranked

39 citations

Yoshikazu Honda‐Okubo, Jeremy Baldwin, Richard A. Bowen, Helle Bielefeldt‐Ohmann, Nikolai Petrovsky +1 more

A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates

Vaccine(2022)10.1016/j.vaccine.2022.06.043

N/A

0DataRank · unranked

6 citations

Robert T. Cartee, Ann Thanawastien, Jae Seung Yang, Kevin Killeen, Nikolai Petrovsky +1 more

An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection

Vaccine(2023)10.1016/j.vaccine.2023.08.009

N/A

0DataRank · unranked

14 citations

E. Bart Tarbet, Brett L. Hurst, Nikolai Petrovsky, Yoshikazu Honda‐Okubo

Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants

Immunology(2023)10.1111/imm.13661

N/A

0DataRank · unranked

12 citations

Anna Antipov, Greiciely O. André, Saghar Barati, Hamidreza Kafi, Nikolai Petrovsky +1 more

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge

Vaccine(2023)10.1016/j.vaccine.2023.06.063

N/A

0DataRank · unranked

11 citations

Lei Li, Greiciely O. André, King Ho Leong, Elizabeth W. Howerth, Anne G. Bebin-Blackwell +3 more

Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants

Vaccine(2023)10.1016/j.vaccine.2023.10.018

N/A

0DataRank · unranked

8 citations

Richard A. Bowen, Mckinzee Barker, Helle Bielefeldt‐Ohmann, Nikolai Petrovsky, Yoshikazu Honda‐Okubo

A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad589

N/A

0DataRank · unranked

6 citations

Richard Woodman, Yoshikazu Honda‐Okubo, J. A. J. Barbara, Derek P. Chew, Barbara Toson +2 more

An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice

Vaccine(2023)10.1016/j.vaccine.2023.07.061

N/A

0DataRank · unranked

5 citations

Isaac G. Sakala, Greiciely O. André, E. Bart Tarbet, Brett L. Hurst, Nikolai Petrovsky +1 more

Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice

Vaccine(2023)10.1016/j.vaccine.2023.08.053

N/A

0DataRank · unranked

6 citations

Yoshikazu Honda‐Okubo, Nikolai Petrovsky, Isaac G. Sakala

Simplified scalable synthesis of a water-soluble toll-like receptor 2 agonistic lipopeptide adjuvant for use with protein-based viral vaccines

Bioorganic Chemistry(2024)10.1016/j.bioorg.2024.107835

N/A

0DataRank · unranked

5 citations

Arshpreet Kaur, Madhuri T. Patil, Yoshikazu Honda‐Okubo, Nikolai Petrovsky, Deepak B. Salunke +1 more

Structure−Activity Relationships Towards the Identification of High-Potency Selective Human Toll-Like Receptor-7 Agonist

ChemRxiv(2024)10.26434/chemrxiv-2024-20xp1

N/A

0DataRank · unranked

1 citations

Arshpreet Kaur, Madhuri Patil, Binita Sihag, Sakshi Piplani, Isaac G. Sakala +5 more

Immunogenicity in mice and non-human primates of an Advax-CpG55.2-adjuvanted recombinant hemagglutinin seasonal quadrivalent influenza vaccine

Vaccine(2025)10.1016/j.vaccine.2025.126707

N/A

0DataRank · unranked

1 citations

Utsav Vaghasiya, Nikolai Petrovsky, Yoshikazu Honda‐Okubo

A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization

Vaccine(2021)10.1016/j.vaccine.2021.07.037

N/A

0DataRank · unranked

18 citations

Yoshikazu Honda‐Okubo, Lei Li, Jeremy Baldwin, Nikolai Petrovsky, Isaac G. Sakala

Advax®-adjuvanted inactivated influenza vaccine provides accelerated protection of mice via early induction of an influenza-specific IgM response

Vaccine(2025)10.1016/j.vaccine.2025.127144

N/A

0DataRank · unranked

1 citations

Isaac G. Sakala, Lei Li, Helle Bielefeldt‐Ohmann, Yuri Lebedin, Nikolai Petrovsky +1 more

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection

Vaccines(2021)10.3390/vaccines9111235

N/A

0DataRank · unranked

14 citations

Yoshikazu Honda‐Okubo, Jeremy Baldwin, Nikolai Petrovsky, Tomoyoshi Komiya